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Abstract
Background: Hemorrhage is a direct consequence of traumatic injury to the central nervous system and may
cause innate immune reactions including cerebral Toll-like receptor (TLR) 4 upregulation which usually leads to
poor outcome in the traumatic brain injury. In spinal cord injury (SCI), however, how hemorrhage induces innate
immune reaction in spinal parenchyma remains unknown. The present study aimed to see whether blood
component and/or other factor(s) induce TLR4 and microglia/macrophages involved innate immune reactions in
the rat spinal cord after traumatic injury.
Methods: Using the compressive SCI model of the rat, hemorrhage in the spinal cord was identified by
hematoxylin-eosin staining. Microglia/macrophage activation, TLR4 expression, and cell apoptosis were investigated
by immunohistochemistry. Nuclear factor (NF)-κB p50 level of the two segments of the cord was detected by
western blotting assay. With carbon powder injection, blood origination of the hematoma was explored. The
blood-spinal cord barrier (BSCB) states of the lesion site and the hematoma were compared with
immunohistochemistry and tannic acid-ferric chloride staining.
Results: Histological observation found blood accumulated in the center of compression lesion site (epicenter) and
in the hematoma approximately 1.5 cm away from the epicenter. TLR4 expression, microglia//macrophage
activation, and subsequent apoptosis in the area of far-away hematoma were late and weak in comparison to that
in epicenter. In addition, TLR4 positive microglia/macrophages appeared to be phagocytotic in the far-away
hematoma more obviously than that in the epicenter. Injected carbon powder indicated that accumulated blood of
the far-away hematoma originated from the bleeding of the lesion epicenter, and the BSCB around the hematoma
was not compromised in the early phase. Accordingly, at 3 days post injury, NF-κB p50 was upregulated based on
the similar levels of blood component hemoglobin, and cell apoptosis was obvious in the epicenter but not in the
far-away hematoma.
Conclusion: These data suggest that besides blood component, BSCB compromise and the extent of tissue injury
contribute more to TLR4 and microglia/macrophage responses to the spinal cord hemorrhage. Therefore, the innate
immune environment is a necessary consideration for the SCI therapy targeting TLR4 and microglia/macrophages.
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Background
Intraparenchymal hemorrhage is a direct consequence of
traumatic injury to the central nervous system (CNS),
and the blood entered in the parenchyma may cause a
serial responses including innate immune reactivity and
becomes neurotoxic [1]. How the innate immune system
of the CNS responds to the hemorrhage is critical for
understanding the mechanisms of the secondary injury
and making the therapeutic strategies.
As an important class of innate immune receptors,
Toll-like receptors (TLRs) expressed on CNS glia and
neurons may recognize endogenous ligands as well as
invaded pathogen and participate both in development
and in responses associated with CNS injury [2]. TLRs
have been implicated in both infectious and non-
infectious CNS pathology and appear to play important
roles in both tissue surveying and repair, and have been
considered as therapeutic targets in CNS inflammation
and infection [3]. Among the members of TLR family,
TLR2 and TLR4 recognize damage molecular pattern
(DAMP) as well as pathogen molecular pattern (PAMP)
to mediate frontier defense in the CNS [4]. DAMP com-
prises cell debris, heat shock proteins released from dead
neurons, fibrinogen, and other molecules that may dam-
age the healthy tissue further [5]. Therefore, TLR2 and
TLR4 are critical for injury induced immune reaction of
the CNS. There has been a growing body of evidence
that brain trauma induces TLR2 and/or TLR4 upregula-
tion [6-8]. Accumulated studies showed that TLR4 was
upregulated in intracerebral hemorrhage (ICH) [9,10],
and TLR4 mediated inflammation may lead to poor out-
come in these individuals [11]. Moreover, it has been
documented that heme, the main component of erythro-
cyte, activated TLR4-mediated inflammatory injury in
ICH [12].
Spinal cord injury (SCI) as a severe traumatic injury to
the CNS usually leads to paralysis and sensation disabil-
ity, and there is still no effective therapy [13]. SCI occurs
commonly in modern society because of traffic acci-
dents, sports accidents, and falling from high buildings.
The spinal cord is part of the CNS, connecting the brain
and the peripheral nervous system, however, whether or
how TLR4 responds to hemorrhage after traumatic SCI
still lacks report.
In our previous study with the rat SCI model, we
documented that TLR4 mRNA was upregulated in
the injured spinal cord, and early blockade of down-
stream signal of TLRs may reduce inflammatory reac-
tion and be helpful to neuroprotection [14], but
whether TLR4 is upregulated by hemorrhage, even
by blood component in the spinal cord remains
unknown.
Pathologically, SCI was divided into primary injury
and secondary injury phases [15,16]. Hemorrhage, bone
fracture, tissue damage, and cell death directly resulted
from violent forces belong to primary injury, which initi-
ates serial lesion called secondary injury. The secondary
injury phase is the only part that could be interposed to
rescue or protect the cord because the primary injury is
unexpected. Primary injury-induced inflammation, ische-
mia, and hypoxia are considered the pivotal factors that
determine the outcome of SCI, but the mechanisms of
the secondary injury are still not fully understood [17].
TLR signals tailor the innate immune response [18],
which is vital for the CNS restoration of tissue repair
and hemoestasis [19]. Therefore, to reveal TLR4 re-
sponse to hemorrhage in SCI would be helpful to further
understand the role of hemorrhage in the secondary
spinal cord injury.
In our previous study on SCI models, we found that
hematoma distal to the center of the lesion site often oc-
curred in the compressive injury to the rat spinal cord.
Preliminary observation indicated that microglia be-
haved differently in these hemorrhagic foci. We hypothe-
sized that hemorrhage induced the innate immune
reaction in the spinal cord, and the lesion center and the
peripheral hematoma may produce TLR4 and microglia/
macrophage responses differently due to the innate im-
mune environment other than the blood component. In
this study, microglia/macrophage activation and TLR4
response to hemorrhage in the distal hematoma as well
as in the epicenter of the lesion were investigated. Dis-
tinct pattern of microglia/macrophage activation and
TLR4 activities were seen in the epicenter and distal
hematoma. Meanwhile, since hemorrhage resulting from
a vascular event also means blood-spinal cord barrier
(BSCB) breakdown which exposes the CNS to circula-
tion and causes neurotoxic effect [19], the present study
also explored the origination of the blood in the distal
hematoma and the BSCB states in the hemorrhagic
areas. The data indicated that different situations of
BSCB compromise might contribute more to those dif-
ferent innate immune responses. These findings may
give new insight to spinal cord hemorrhage as well as
the innate immune reaction of SCI.
Methods
Animals and experimental protocol
Male Sprague–Dawley rats (approximately 220–250 g),
provided by the Experimental Animal Center of the
Fourth Military Medical University, were maintained
with temperature (approximately 22-25°C) and light
(12-h light/dark cycle) control, and had free access to
water and food. All the experiments involving animals
were approved by the Animal Care Committee of the
Fourth Military Medical University.
A spinal cord compressive model was made, and ani-
mals were randomly divided into various groups. The
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numbers of animals assigned to those experiments are
shown in Table 1. At 6 h, 3 days, and 14 days post
injury, animals were sacrificed by intra-cardiac perfu-
sion with 4% paraformaldehyde, and the spinal cord
were removed and sectioned for histological observa-
tion. Another batch of animals was sacrificed by
decapitation and their spinal cords were taken for
western blotting assay. To explore the source of
blood forming distal hematoma, carbon powder was
injected into the compressive epicenter before com-
pression, and hemisection in dorsal cord were made
in six other rats. In order to explore the BSCB
compromise, six rats were subjected to tannic acid-
ferric chloride staining and immunohistochemistry for
rat IgG.
Compressive spinal cord injury model
Compressive injury model was performed as previously
reported [20]. A 20 g metal rod was used to make the
compress injury (Figure 1). The tip of the rod was cov-
ered with a plastic plate which is approximately 2.6
to 2.9 mm wide (depends on the diameter of the
cord) and 0.5 mm thick. The rod was held by a metal
tube which controls the position and the depth of the
rod via connection with the sterotaxic apparatus but
does not press the rod anytime. Before the compres-
sion injury, the rat was anesthetized with 1% sodium
pentobarbital (50 mg/kg, i.p.), a 30–40 mm dorsal
midline incision was made, then the spinal cord was
exposed by a bilateral laminectomy of T8 vertebra
(corresponding to T9 segment of the spinal cord),
with the dura intact. Then the vertebral column was
fixed with stabilizing forceps and the rod was placed
onto the spinal cord, with the plastic plate perpen-
dicular to the longitudinal axis of spinal cord, and
the tip attached the dura surface. After that, the
metal tube was moved down vertically at a speed of
0.5 mm/min with the sterotaxic apparatus to produce
compression onto the spinal cord by the weight of
the rod. After 5 min, the plastic plate was lowered to
the bottom of the vertebral canal to achieve a full
compression of the cord. The rod was remained at
this position for 1 min, followed by a slow withdraw
within 1 min. The wound was closed by suturing
muscles and skin over the vertebral column. The rats
were kept in cages with soft bedding, and manual
evacuation of urinary bladder was performed twice
daily.
Table 1 Animal assignment for all experiments and time
points
6 h 3 days 14 days
H-E and immunohistochemistry 3 4 3
Western blotting assay 4
Carbon powder injection 3
Hemi-transection 3
Tannic acid-Ferric chloride staining 3
Figure 1 The device for the compressive spinal cord injury model of the rat. (A) The metal tube and the rod with a plastic plate attached
onto the tip. (B) The rod is held by the tube which could be connected with the stereotaxic apparatus. (C) Schematic diagram of compressive
injury to the spinal cord by the plastic plate attached to the rod tip, (a) front view and (b) side view.
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Histological observation
Rats were sacrificed at 6 h, 3 days, or 14 days post injury
by an overdose of sodium pentobarbital (100 mg/kg) and
perfused intra-cardially with 100 mL of warm normal sa-
line followed by 400 mL 4% cold paraformaldehyde in
phosphate buffer (pH 7.4). After perfusion, a 2-cm-long
spinal cord segment, with the injured site in the middle,
was removed and put into 25% sucrose in phosphate
buffer at 4°C until it sank to the bottom of the container
(at least 12 h). Then serial 20 μm frozen sagittal sections
were cut with a cryostat and mounted on slides in eight
sets for hematoxylin and eosin (H-E) staining and
immunohistochemistry.
For H-E staining, sections were rinsed in distilled
water and were stained in hematoxylin solution for
5 min. After washing with running tap water for
5 min, the sections were differentiated in 1% acid-
alcohol for 30 s and were washed again with tap
water for 1 min. Then the sections were put into
Eosin for 30 s, and were dehydrated through 70%,
80%, 90%, and 100% alcohol for 2 min each. After
two changes of xylene, sections were covered with
xylene-based mounting medium. Then the stained
sections were observed to figure out the lesion site
and hematoma.
For immunohistochemistry, sections were rinsed with
0.01 M phosphate buffer saline (PBS) and then blocked
with 1% bovine serum albumin (Sigma) in PBS
containing 0.5% Triton X-100 for 30 min at room
temperature. Then the sections were incubated with pri-
mary antibody overnight and fluorescence conjugated
second antibody for 2 h. To see the serum protein ex-
travasation in the injured spinal cord, rat immunoglobu-
lin G (IgG) was detected by immunohistochemistry.
Briefly, spinal sections were directly incubated with
Alexa Fluor 488 goat anti-rat IgG for 2 h. Antibodies
against IBa-1 (1:500, rabbit polyclonal, Wako, Tokyo,
Osaka, Japan), ED1 (1:400, mouse monoclonal, Serotec,
Raleigh, NC, USA), TLR4 (1: 200, mouse monoclonal,
Abcam, Cambridge, MA, USA), reactive endothelial cell
antigen (RECA) (1:500, mouse monoclonal, Abcam,
Cambridge, MA, USA) were used. Fluorescence conju-
gated secondary antibodies were purchased from Mo-
lecular Probes, Oregon, USA. Omission of the primary
antibody served as the negative control. The sections
were observed under an Olympus FV1000 laser scanning
confocal microscope.
Western blotting assay
At 3 days post compression SCI, animals were deeply
anesthetized and sacrificed by decapitation (n = 4).
Spinal cord tissues of 3 cm, with epicenter of the injury
in the middle, were removed rapidly. Then the spinal
cord was divided into three parts equally as rostral,
Figure 2 Compressive spinal cord injury caused distal hematoma far away from the lesion site. (A) A segment of rat spinal cord taken
out immediately after compression. Aster shows the compressive point, and the arrow shows the distal hematoma which could be seen grossly.
(B-D) H-E staining of the spinal cord sections indicated blood in the compressive lesion center and far-away hematoma which forms spindle-
shaped foci at 6 h, 3 days, and 14 d post injury, respectively. (E-G) Higher magnification of the boxes in the pictures above accordingly. Note that
cavity formed from the hematoma at 14 days post injury. Bar = 1 mm (A-D), 200 μm (E-G).
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central, and caudal segments, 1 cm of each. All the
spinal cord segments were stored in liquid nitrogen and
then processed for extraction of protein. Briefly, tissue
samples were homogenized with 0.5 mL of ice-cold lysis
buffer (20 mM Tris–HCl, pH 7.5, 1 mM EDTA, 5 mM
MgCl2, 1 mM DTT, 20 μg/mL aprotinin, 1 mM PMSF,
and 2 mM sodium orthovanadate). The homogenates
were centrifuged at 13,000 rpm for 10 min at 4°C and
supernatant were removed. The protein concentration
was determined using Bradford method, a detergent-
compatible protein assay with a bovine serum albumin
as standard. Samples were boiled at 100°C for 10 min
and then were electrophoresed on 10-15% SDS-PAGE
and transferred onto a nitrocellulose membrane
(Millipore, Bedford, MA, USA). The filter membranes
were blocked with 5% BSA for 1.5 h at room
temperature and incubated with the primary antibody
(NF-κB p50, 1:5,000, Epitomics, CA, USA; phospho-IκB,
1:10,000, Epitomics, CA, USA; Homeglobin-alpha,
1:2,000, Epitomics, CA, USA, β-actin, 1:5,000, Cwbiotec,
Beijing, China) for approximately 16 to 24 h at 4°C. The
membrane was then washed with TBST buffer and
incubated with the secondary antibody conjugated
with horseradish peroxidase (1:5,000; Cwbiotec, Beijing,
China) for 1 h at room temperature and visualized in
ECL solution. The density of specific bands was mea-
sured with Image J (NIH, USA) software.
Statistical analysis of the density of the specific bands
was made with software SPSS 16.0. Density of band
NF-κB p50 and phosphor-IκB were compared with that
of Hemoglobin-alpha, respectively, then the ratio of NF-
κB p50/hemoglobin-alpha, phosphor-IκB/ hemoglobin-
alpha of lesion segments, and far-away hematoma
segments were analyzed by paired T test (segments of
Figure 3 Blood origination of the far-away hematoma. (A) H-E staining pictures show that there is no hematoma far away from lesion site in
the spinal cord with semi-transection (arrow) aside the lesion. (B) Distal hematoma contained carbon powder injected to the compression center
immediately after injury, indicating that blood originated from the lesion site. (C) and (D) are higher amplified pictures of the boxes located in
the lesion site (indicated by letter L) and distal hematoma (indicated by letter H) in (B), showing carbon powders (arrows) inside the hemorrhagic
foci. Bar = 2 mm in (A) and (B). Bar = 50 μm in (C) and (D).
Zhang et al. Journal of Neuroinflammation 2013, 10:112 Page 5 of 15
http://www.jneuroinflammation.com/content/10/1/112
the same spinal cord was paired, n = 4); P value at 0.05
was considered significant.
Origination of blood in distal hematoma
In order to find out the source of the blood that formed
hematoma distal to the lesion site, carbon powder injec-
tion experiment was designed. Immediately after the
compressive injury was completed, 1 μL PBS containing
0.1 g/mL fine carbon powder was injected slowly with a
microsyringe into the lesion site, at a depth of approxi-
mately 1 mm. After injection, the tip of syringe was kept
for 2 min and was withdrawn carefully. The whole
process was completed within 10 min.
In the case that bleeding from the lesion may expand
to the distal area, transection between the lesion site and
the distal area could be a barrier to impede formation of
distal hematoma. To prove this hypothesis, dorsal
hemisection was made in another group of animal im-
mediately after compression. At sites approximately 0.3
to 0.4 mm rostral and caudal to lesion center, dorsal
hemisection was made with a sharp blade at a depth of
approximately 1 mm.
All these animals were killed by intra-cardiac perfusion
with 4% paraformaldehyde, and the spinal cord was sec-
tioned for histological analyses.
Blood vessel integrity
BSCB may determine the innate immune reaction. Here
in this study, tannic acid-ferric chloride staining plus re-
active endothelial cell antigen (RECA) immunohisto-
chemistry were used to show vascular integrity. Firstly,
RECA immunolabeling was performed in the spinal sec-
tion at 6 h post injury, to show the existence of blood
vessels in both hemorrhage foci, since RECA is bio-
marker of endothelial cells. Another batch of animals
was killed at 6 h post injury by perfusion with tannic
acid and ferric chloride to cover the endothelial cells of
the blood vessel. The spinal sections from these animals
will be immunolabeled by RECA later. The broken down
blood vessels may not be well perfused with tannic acid-
ferric chloride, so the RECA immunoreactivity would be
positive; otherwise, the endothelial cells of the intact
blood vessels would not be labeled with RECA.
Animals were anesthetized with an overdose of sodium
pentobarbital and were perfused through intracardially
Figure 4 Microglia/macrophage activation in the spinal area adjacent to the lesion site but not around the distal hematoma at 3 days
post injury. (A) Montage picture of longitudinal spinal cord section for IBa-1 immunolabeling, showing lesion site (indicated by letter L) and
hematoma (indicated by letter H) at 3 days post injury. (B) Amplified picture of the box adjacent to the lesion site, showing many cells are
labeled with both IBa-1 (red), the marker of microglia, and ED-1(green), the marker of activated microglia. (C) Amplified picture of the box
adjacent to the far-away hematoma in which only IBa-1 positive cells with thin processes could be seen. Bar = 2 mm in (A). Bar = 50 μm in (B)
and (C).
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with saline (37°C) followed by 4% paraformaldehyde,
2% tannic acid, and 0.5% glutaraldehyde in 0.01 M PBS
(37°C). Then 250 mL ferric chloride solution (3%, 37°C)
was perfused immediately and spinal cord was removed
promptly after the perfusion.
Results
Histological profile of hemorrhage
As shown by H-E staining, hemorrhage in the spinal
cord formed two distinct foci, the compressive lesion
area and the far-away hematoma. The hematoma usually
appeared in the caudal, dorsal part of the cord, approxi-
mately 1.5 cm away from the epicenter of the injury,
which could be even seen grossly (Figure 2A). Distal
hematoma was spindle shaped with clear limitation to
spinal cord parenchyma. At 6 h post injury, the far-away
hematoma formed, while it developed continuously to a
larger hematoma till 3 days post injury. Later at 14 days
post injury, the spindle-shaped hematoma became a cav-
ity (Figure 2B-G).
Carbon powder injected into the epicenter of the in-
jury indicated that the far-away hematoma may originate
from the lesion site, because in the far-away hematoma,
carbon powder which was injected to the lesion site
immediately after the compression was found 6 h post
injury (Figure 3B-D). Moreover, in the compression in-
jured spinal cord with hemi-transection in the dorsal
part at rostral and caudal sides, there was no far-away
hematoma formed even at 3 days post compression
(Figure 3A).
TLR4 expression and microglia/macrophage activation
Immunohistochemistry showed that TLR4 immunoreac-
tivity and activated microglia/macrophage could be seen
in both lesion site and far-away hematoma, but differ-
ently in time points and distribution.
At 6 h post injury, the immunolabeling of TLR4 and
IBa-1 was similar in the lesion site and the hematoma.
Some of the IBa-1 positive cells appeared bigger than
those in the hematoma, and TLR4 immunolabeling
Figure 5 Immunofluorescent labeling for TLR4 and IBa-1 in the lesion site and the hematoma at 3 days post injury. In the lesion site
(A-C), there were abundant IBa-1 positive cells, quite part of which express TLR4, showed by confocal microscopy. Most of the microglia/macro
phages were round with short or blunt processes. To the contrast, in the distal hematoma and the area adjacent to it (D-F), there were few TLR4
positive cells, and IBa-1 labeled cells were small with thin processes. TLR4 immunoreactivity: red; IBa-1 immunoreactivity: green; Hoechest 33342:
blue. Bar = 200 μm.
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could be found but only in several cells in the epicenter
(data not shown).
At 3 days post injury, a large number of microglia/
macrophage appeared in the epicenter, and most of them
were activated, indicating by ED1 immunoreactivity and
the shape of the cells (Figure 4B). While in the area adja-
cent to the hematoma far away from the lesion site,
most of the IBa-1 positive cells are not ED1 labeled, and
their cell body remained small and the processes were
thin (Figure 4C).
Coming to the TLR4 immunoreactivity, similar pro-
file as microglia/macrophage activity was found.
Namely, at 3 days post injury, TLR4 immunolabeling
were seen in the center of the compressive lesion,
and most of the labeling was co-located with round
microglia/macrophage, indicating by confocal micro-
scopy. At the same time point, little TLR4 could be
seen in the area of hematoma. Apart from the area
around, there were few IBa-1 positive cells inside the
hematoma. The distribution of IBa-1 immunoreactiv-
ity was clearly limited according to the border of the
hematoma (Figure 5).
TLR4 immunoreactivity was increased in the hemato-
ma far away from the epicenter of the lesion at 7 days
(not shown) and 14 days, which is nearly parallel to the
activation of microglia/macrophage. At 14 days, strong
TLR4 labeling was seen within the hematoma but not in
the adjacent area (Figure 6C, G, K). This profile of TLR4
immunolabeling and microglia/macrophage was similar
to that of epicenter at 3 days post injury. Notably, it was
clearly shown by confocal microscopy that TLR4 immu-
noreactivity was located inside the IBa-1 positive cells
Figure 6 Representative pictures of immunofluorescent labeling for TLR4 and IBa-1 in the far-away hematoma at 6 h, 3 days, and
14 days post injury. Note that IBa-1 positive cells are small and scattered in the area adjacent to the hematoma at 6 h (A, E, I) and appear in
the hematoma at 3 days post injury (B, F, J). At 14 days post injury (C, G, K), TLR4 immunoreactive product is seen in the area of the hematoma,
and abundant IBa-1 positive cells are large and phagocytotic and with TLR4 immunoreactivity inside the cytoplasm. All of these observation is
similar to the lesion site at 3 days post injury (D, H, L), and the stack of scanning pictures of confocal microscopy confirmed that TLR4 immuno-
reactive product was located in the cytoplasma of IBa-1 positive cells (L). TLR4 immunoreactivity: red; IBa-1 immunoreactivity: green; Hoechest
33342, blue. L, lesion site; H, hematoma. Bar = 50 μm.
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which were extremely activated as their soma became
large and round like huge bubbles (Figure 6D, H, L).
Cell apoptosis around hemorrhage
With immunofluorescent labeling, one can see abundant
capase-3 positive cells in the lesion site at 3 days, but
very few cells in the far-away hematoma at the same time
point. However, the number of capase-3 immunoreactive
cells markedly increased in the area around hematoma at
14 days post injury (Figure 7).
NF-κB upregulated more in lesion site
In order to compare the inflammatory signal down-
stream TLR4, we detected the NF-κB p50, phosphory-
lated inhibitor of kappa B (p-IκB) protein levels of the
spinal segment of lesion site and the segment of
Figure 7 Immunofluorescent labeling for caspase-3 at 3 days and 14 days post injury. Representative microscopic photos show numbers
of caspase-3 immunoreactive cells inside the lesion area at 3 days post injury (A), while only few cells are caspase-3 positive (arrow) in the area of
or adjacent to hematoma (B). At 14 days post injury, there are casepase-3 positive cells in the lesion site but decreased in number (C); while in
the area adjacent to the hematoma, caspase-3 immunoreactive cells are markedly increased (D), compared to that at 3 days. TLR4 immunoreacti-
vity, red; IBa-1 immunoreactivity, green; Hoechest 33342, blue. L, lesion site; H, hematoma. Bar = 50 μm.
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hematoma at 3 days post injury, based on hemoglobin-α
level which was used to represent red blood cells. Re-
petitive western blotting assay showed that ratio of
NF-κB p50/hemoglobin-αlevel was higher in the lesion
segment than that in the hematoma segment. The ratio
of p-IκB /hemoglobin-α was consistent, statistical ana-
lysis showed the differences were both significant
(Figure 8).
Blood-spinal cord barrier compromised
Immunohistochemistry for RECA showed that there
were blood vessels in lesion site and the far-away
hematoma at 6 h post injury. However, spinal cord of
animals that were perfused with tannic acid-ferric chlor-
ide before sacrifice, RECA positive labeling could only
be found in the lesion area, but not in the far-away
hematoma, indicated the integrity of blood-vessels in the
area of hematoma (Figure 9).
Shown by immunohistochemistry, rat IgG immunore-
active labeling could be seen in the lesion site and
around area of the injured spinal cord at 3 days after
compression. However, there was very little IgG immu-
noreactivity in the far-away hematoma (Figure 10).
Discussion
A previous study showed in the SCI model that transec-
tion injury caused vascular event in the spinal cord distal
to the transection site, and exhibited a more pronounced
vascular disruption than at comparable sites proximal to
the injury [21]. However, we showed in the compressive
SCI rat model that the BSCB disruption was less severe
in the distal hematoma than in the lesion site. Compared
to the ICH model made by blood injection [10,11,22],
this far-away hematoma in the spinal cord provides a
condition in vivo in a natural way that blood component
contacts the parenchyma of the CNS. In this model, the
innate immune reaction induced by blood could be eas-
ily observed.
In this case of far-away hematoma, the profiles of
TLR4 response and microglia/macrophage activation
were found distinct from that in the lesion center. As
described in the results session, although the far-away
hematoma appeared at 6 h post injury (it could be even
earlier in fact), TLR4 upregulation and microglia/macro-
phage activation in the far-away hematoma were late
and weak, compared to that in the epicenter of the
lesion. Generally, at 3 days post injury, TLR4 expression
was increased to peak in the epicenter, but TLR4
expression was in low level and microglia/macrophage
remained resting in the hematoma area at the same time
point. Even later at 14 days post injury, TLR4 and micro-
glia/macrophage activity in the hematoma was not as
strong as that in the epicenter at 3 days post injury.
To explain the difference of the innate immune
reaction between these blood-comprised foci, one can
easily considered that primary injury in the lesion site
Figure 8 Western blotting assay for NF-κB p50, phosphorylated-IκB in the lesion segment and far-away hematoma segment of the
spinal cord at 3 days post injury. (A) Representative picture of immunoblots for NF-κB p50, β-actin, phosphorylated-IκB (p-IκB), and hematoglo-
bulin (Hb)-α, respectively. (B) Bar graph of ratio of the blot pixels for NF-κB p50 and p-IκB calibrated by Hb-α in lesion and hematoma segments,
respectively (n = 4 for each group, *P <0.05). H, hematoma; L, lesion site.
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produced abundant necrotic cells and cell debris, the en-
dogenous DAMP that could activate TLR4; while the area
around the far-away hematoma was relatively clear. In
addition, heat shock proteins (HSPs) released from the
damaged neurons activated microglia [23] and triggered
the expression of TLR4 on the surface of microglia/macro-
phage [24]. In the injured spinal cord, high-mobility group
box-1 protein and its receptors including TLR4 were in-
creased at early stage [25]. Necrotic neurons were found
to activate microglia via TLR-MyD88 pathway which in
turn mediated enhanced neurotoxicity by activated micro-
glia through upregulation of the expression and activity of
glutaminase [26]. Based on such environment, the
hemorrhage in the lesion site may exacerbate early
upregulation of TLR4 in the microglia/macrophage, and
initiate pro-inflammation cascade. The hematoma which
was far away (around 1.5 cm) from the lesion site, how-
ever, containing mainly red blood cells and perhaps a little
serum, caused little tissue damage, as shown by H-E stain-
ing. This relatively intact tissue environment attributed to
the late and weak responses of TLR4 and microglia/
macrophage to blood.
Another environmental factor which led to the differ-
ence could be the BSCB states in the lesion site and the
Figure 9 Microvascular and capillary integrity of the spinal cord in the lesion site and the far-away hematoma. (A) Representative
picture of the longitudinal spinal cord section labeled for RECA without ferric-chloride perfusion at 6 h post injury. (B) and (C) are amplified
pictures of the boxes in lesion site and hematoma, respectively, showing that small blood vessels were there in the lesion site and in hematoma
as well. (D) Representative picture of the longitudinal spinal cord section labeled for RECA after tannic acid and ferric-chloride perfusion, showing
nearly no RECA immunoreactivity. (E) and (F) are amplified pictures of the boxes in lesion site and hematoma, respectively, showing that RECA
immunolabeling only in the lesion site. Bar = 2 mm in (A) and (D), 50 μm in (B), (C), (E) and (F).
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hematoma area. BSCB compromise could be found in
different SCI models by observation of blood-borne pro-
tein extravasation. In contusive injury models, BSCB dis-
ruption depended on the severity of the injury and days
after injury. By 7 days post injury, despite resolution of
the initial hemorrhage, there remained scattered evi-
dence for protein extravasation at the injured site and at
sites along the axis of the cord [27]. In the impactor-
induced spinal cord contusion, such plasma protein ex-
travasated in segments of the spinal cord located away
from the compressed part [28]. Here in the present
study, BSCB compromise caused by compression mainly
restricted in the lesion site, indicated by IgG immunore-
active product. Through the broken BSCB, plasma pro-
tein such as albumin extravasated into the parenchyma
and induced innate immune reaction mediated by
microglia and other neural cells [29].
More importantly, broken capillaries mean hemor-
rhage and ischemia in the lesion area. A prominent in-
flammatory response occurs following both ischemic
and hemorrhagic stroke, thereby exacerbating secondary
injury [30,31]. This study showed clearly with the experi-
ment of carbon powder injection that (at least part of )
the blood in the far-away hematoma originated from the
lesion site. The hemi-transection aside of the lesion area
impeded the occurrence of hematoma far away from the
lesion site, which further indicated the identical origin-
ation of the hematoma. Such blood origination implied
that most local blood vessels and capillaries remained in-
tact in the area far away from the lesion site of the spinal
cord. This was proven by the tannic acid-ferric chloride
perfusion experiment. As tannic acid-ferric chloride
perfusion covered the integrate blood vessels, the
endothelial cells could not be labeled by RECA
immunohistochemistry; in turn, the RECA labeled were
broken capillaries. Without tannic acid-ferric chloride
perfusion, RECA immunolabeling showed capillaries
both in lesion site and the hematoma, but RECA label-
ing was seen only in the lesion area after tannic-ferric
chloride perfusion, indicating that capillaries, namely
BSCB was compromised there. To the contrast, BSCB
remained relatively intact in the area adjacent to
hematoma, therefore little ischemia or hypoxia occurred
this area. Subsequently, the innate immune reaction
was weak and late though blood component directly
contacted the parenchyma.
Noticeably, the profile of TLR4 and microglia/macro-
phage responding to hemorrhage in the spinal cord
seems different from that in the brain. First, there was
nearly no hematoma away from the hemorrhagic or
injury center in those ICH models. The far-away
hematoma in this SCI model may be due to the spinal
cord structure which restricts the hemorrhage to the
white matter of the dorsal columns [1]; while the cere-
bral hemorrhage has little expansion space within the
brain parenchyma, so the blood usually stays in the
original BBB disruption area. Second, the blood injected
to the brain parenchyma seemed comparable to the
hematoma away from the epicenter in the spinal cord,
but the injected blood in the brain induced TLR4-NF-κB
signal activated from 1 day after hemorrhage, and
peaked at 3 days [10-12,32], a profile similar to that of
epicenter of SCI model. It appears controversial for the
blood component to induce TLR4/microglia responses
at early phase in the CNS. However, the blood injection
was somehow apt to compromise the BBB indicating by
brain water content and/or Evans blue extravasation
[12]. Even in the experimental subarachnoid cerebral
Figure 10 Representative picture of immunohistochemistry for rat immunoglobulin G (IgG) in the spinal cord at 3 days post injury.
(A) IgG immunoreactive product is obvious in the lesion area (left box), while in the far-away hematoma (right box), there is little immunolabe-
ling for IgG. (B) and (C) are higher magnification of the boxes in the areas adjacent to the lesion site and to the hematoma, respectively.
Bar = 2 mm in (A), 200 μm in (B) and (C).
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hemorrhage model made by injection of blood into the
prechiasmatic cistern, BBB breakdown was found 48 h
post injection [22]. Therefore, the BBB compromise at
early phase may enhance TLR4 involved innate immune
responses in the blood injection models, which is differ-
ent from the situation of the far-away hematoma in the
present study.
It has been well studied that TLR4 activation leads to
extensive neuron death in vitro that depends on the
presence of microglia [33]. Further study demonstrated
that HSP60-induced neuronal injury displays character-
istics of apoptosis and is dependent on a functional
TLR4-MyD88 [24]. In the present study, apoptosis was
detected by immunohistochemistry for caspase-3, the
key enzyme of the apoptosis progress [34-36], in the epi-
center of the lesion site and the area adjacent to the far-
away hematoma at different time points which coincide
with that of TLR4/microglia activity. According to the
result of western blotting assay, the level of p-IκB was
higher, namely more NF-κB was free to translocate into
the nuclear [37,38], at 3 days post injury in the lesion
site than in the hematoma segment based on the similar
hematoglobin level. These data are consistent with the
previous reports about microglial TLR4/NF-κB signal in-
duced subsequent neural cell apoptosis [24,39].
In addition to the late and weak upregulation, TLR4
expression and microglia/macrophage activation in the
far-away hematoma were closely associated with phago-
cytosis, as indicated by morphological observation that
TLR4 immunoreactive product was located within the
microglia/macrophages. While in the lesion site, such
phagocytotic microglia/macrophages with TLR4 immu-
noreactivity did not appear so obvious. As an innate im-
mune receptor, TLR4 plays roles in clearance of DAMPs
such as A-beta peptides [23,40], and microglia/macro-
phage also delete the cell debris by phagocytosis [41].
Meanwhile, cavitation occurred in the site of the far-
away hematoma as observed at 14 days post injury.
Therefore, TLR4 and microglia/macrophage phagocyt-
osis in the present study may link the clearance of the
blood and the cavitation in the spinal cord, particularly
in the hematoma. Since the cavity formation in the
spinal cord is associated with protection to the spared
cord and recovery from the injury [42], these TLR4 and
microglia/macrophage responses should benefit recovery
from the spinal cord injury.
The different profiles of TLR4 and microglia/macro-
phage responses to the intraparenchymal hemorrhage
further reflect the complexity of SCI. Owing to its com-
plexity, a spinal cord injury is unlikely to be cured by a
single therapy [17]. Even TLR4 is taken as the thera-
peutic target, the proper time window of treatment as
well as the innate immune environment of the spinal
cord are the prerequisites for a success therapy.
TLRs have been implicated to play important roles in
both tissue surveying and repair, and have been
concerned as potential therapeutic targets in CNS in-
flammation [3], while TLRs can exert either beneficial or
detrimental effects on the CNS, which probably depend
on the context of tissue homoeostasis or pathology.
Therefore, any potential therapeutic manipulation of
TLRs will require an understanding of the signals
governing specific CNS disorders to achieve tailored
therapy [43]. TLR4 deficiency has been proved by Kilic
and colleagues to be protective to neurons against ische-
mia and axotomy [44], but Kigerl and colleagues found
that TLR2 and TLR4 deficiency may impair the loco-
motor function recovery from SCI [45]. These contro-
versial conclusions might be due to the differences
between the injury models, while the immune micro-
environment should be more important impact factor
that could not be excluded.
As this study was a primary exploration to the
hemorrhage-induced innate immune reaction in the
spinal cord, all these data provided here may be insuffi-
cient to illustrate precisely the relationship between
TLR4/microglia responses and the amount of the blood.
To answer better how blood component and/or other
factor(s) mediate the innate immune response in SCI,
more experiments need to be performed next step, for
instance, TLR4/microglia responses to blood in vitro and
observation to the TLR4/microglia responses at SCI
model with repaired BSCB.
Conclusion
As far as our knowledge, this is the first evidence about
hemorrhage-induced TLR4 expression and microglia/
macrophage activation in the spinal cord of the rats. With
far-away hematoma originated from the lesion site
hemorrhage in the spinal parenchyma, we showed distinct
profiles of TLR4 and microglia/macrophage activation due
to different innate immune environments. These data sug-
gest that hemorrhage in the spinal cord induce the innate
immune reaction involving TLR4 and microglia/macro-
phage activities but require other conditions including tis-
sue/cell damage and BSCB disruption. This study also
indicates that hemorrhage in the spinal cord may be differ-
ent from that in the brain, and the complexity and the
trait of SCI should be considered in the therapeutic strat-
egy targeting the innate immune responses.
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